Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03713424 · ClinicalTrials.gov registry record · Phase 2

An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

A Phase 2 study of Tobacco Use Disorder, sponsored by University of Missouri-Columbia.

Recruiting
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT03713424 is a Phase 2 study of Tobacco Use Disorder that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 30 participants, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03713424, a Phase 2 study of Tobacco Use Disorder, is actively recruiting participants, sponsored by University of Missouri-Columbia.

RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.

Conditions Studied

Tobacco Use Disorder

Interventions

  • DRUG Placebo oral capsule
  • DRUG Clavulanic Acid

Study Locations (1)

Missouri

  • University of Missouri - Columbia - Columbia

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-03-26
Est. Completion 2026-08-31
Phase Phase 2

Sponsor

University of Missouri-Columbia

291 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03713424

The ClinicalTrials.gov registry entry for NCT03713424 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 239-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (87% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo oral capsule is the first listed.

NCT03713424 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03713424 about?

NCT03713424 is a clinical study titled "An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction". This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.

What is the current status of trial NCT03713424?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2019-03-26. Estimated completion is 2026-08-31.

What conditions does trial NCT03713424 study?

This clinical trial studies the following conditions: Tobacco Use Disorder.

What interventions are being tested in trial NCT03713424?

The interventions under investigation include: Placebo oral capsule (DRUG), Clavulanic Acid (DRUG).

Who is sponsoring clinical trial NCT03713424?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03713424 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Use Disorder

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.